CLINICAL_TRIALS
trial_result
· 2019-10-22
Clinical Trial Update: Dose-ranging Study of Nemolizumab in Atopic Dermatitis [Phase 2]
Summary
Phase 2 dose-ranging study of nemolizumab in atopic dermatitis has been completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2019-10-22